eGenesis is a biotechnology company committed to using its multiplex gene editing and genome engineering platform to transform solid organ and therapeutic cell transplantation for the treatment of serious diseases...
At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.